Groowe Groowe / Newsroom / NVS
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

NVS News

Novartis AG

Aplastic Anemia - 7MM Market Insights, Epidemiology, and Forecast - 2036 | HSCT and Cell Therapy Advances Create Opportunities Amid Rising Incidence and Generic Pressure

globenewswire.com
TEVA NVS

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novartis AG - NVS

accessnewswire.com
NVS

The Mark Foundation Awards $12 Million to Cross-Disciplinary Cancer Research Teams

prnewswire.com
NVS MRK BMY GILD AZN PFE JNJ BIIB REGN MDLZ

OncoBayes poursuit le développement de l'OB-001 pour lutter contre la résistance aux anticorps monoclonaux conjugués et améliorer la pénétration des inhibiteurs de tyrosine kinase dans le cerveau

prnewswire.com
NVS GILD

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novartis AG - NVS

globenewswire.com
NVS

Boston, MA Commercial Air Filter Manufacturer Brookaire Now Delivers HVAC Filters to Contractors and Facility Managers Across Massachusetts, Rhode Island, and Connecticut

globenewswire.com
MRNA BIIB VRTX NVS PFE

Japan Cell and Gene Therapy Manufacturing Market Forecast to 2035 | Market to Reach USD 5.15 Billion at 29.0% CAGR as Commercial-Scale Capacity and Gene Therapies Expand

globenewswire.com
TMO CAT CRL AMGN BMY GILD AZN NVS MRK JNJ LLY ABBV

Global Orphan Drugs Market Size, Share, Trends, and Forecast 2026-2034 | Market to Reach USD 589.2 Billion as Genomics, Precision Medicine, and Regulatory Incentives Drive Growth

globenewswire.com
AMGN AZN GNE GSK JNJ MRK NVS PFE SNY BMY REGN BIIB GILD ABBV EXEL CRSP NTLA EDIT INCY VRTX

Orphan Drugs - Global Market Size, Share, Industry Trends, and Growth Forecasts, 2025-2031 | Biologics and Asia-Pacific Drive 6.36% CAGR to USD 334.28 Billion

globenewswire.com
ABBV AMGN AZN BMRN BMY CSL GSK JNJ NVS PFE REGN SNY SRPT VRTX

Global Immunotherapy Drugs Market - Size, Share, Trends, Competitive Landscape, and Forecast - 2034 | Market to Reach USD 837.14 Billion as Cell Therapies Drive 13.05% CAGR

globenewswire.com
MRK BMY NVS ROG AMGN IBIO AZN JNJ GSK IOVA ABBV